RPS26P47

Across TCGA pan-cancer cohorts, RPS26P47 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of RPS26P47’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPS26P47 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS26P47 is over-expressed in tumor.

COAD, LUSC, and STAD are the cancer types where RPS26P47 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS26P47 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.579	.017	4	view →
LUSC	Male	All	+0.236	.001	4	view →
STAD	Female	All	+1.718	.013	3	view →
LUAD	Male	All	+0.390	.010	2	view →
KIRC	Female	IV	+0.368	.034	2	view →
BLCA	All	All	+0.286	.032	2	view →
ESCA	Female	All	+2.306	.009	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

RPS26P47–COAD

Open the COAD breakdown →